Fintel reports that on October 11, 2024, Keybanc initiated coverage of Ardent Health Partners (NYSE:ARDT) with a Overweight recommendation.
Analyst Price Forecast Suggests 22.41% Upside
As of September 25, 2024, the average one-year price target for Ardent Health Partners is $23.23/share. The forecasts range from a low of $21.21 to a high of $28.35. The average price target represents an increase of 22.41% from its latest reported closing price of $18.98 / share.
See our leaderboard of companies with the largest price target upside.
What are Other Shareholders Doing?
Putnam Funds Trust - Putnam Multi-cap Core Fund holds 634K shares representing 0.44% ownership of the company.
HGHAX - THE HARTFORD HEALTHCARE FUND holds 271K shares representing 0.19% ownership of the company.
TSLCX - Transamerica Small Cap Value C holds 52K shares representing 0.04% ownership of the company.
JSFBX - John Hancock Seaport Long holds 32K shares representing 0.02% ownership of the company.
USSCX - Science & Technology Fund Shares holds 4K shares representing 0.00% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
